Catechol-O-Methyltransferase Polymorphism and Endometriosis

Purpose : Catechol-O-methyltransferase (COMT) inactivates the estradiol metabolites, 2-hydroxy and 4-hydroxy catechols, which have been implicated in the pathogenesis of endometriosis. A COMT valine to methionine polymorphism (G-to-A) in exon 4 of the COMT gene is polymorphic in the human population, with 25% of Caucasians being homozygous for the low-activity allele (COMT-L) of the enzyme. In a case-control study we investigated whether this COMT polymorphism is associated with endometriosis.

Polymerase chain reaction was performed to analyze the COMT genotype among women with surgically and histologically confirmed endometriosis (study group; n = 91) and in women without evidence of endometriosis confirmed by laparoscopy or laparotomy (control group; n = 92).

Allele frequencies for the low-activity allele (COMT-L) among women with endometriosis and controls were 0.50 and 0.50, respectively (p = 0.999; odds ratio = 1.0, 95% CI: 0.66–1.51).

Our results suggest that the valine to methionine polymorphism in exon 4 of the COMT gene is not associated with the risk of endometriosis compared to a surgical control population. Similar content being viewed by others

Olive DL, Schwartz LJ: Endometriosis. N Engl J Med 1993;328:1759–1769 Redwine D: Mullerioisis: The single best-fit model of the origin of endometriosis. J Reprod Med 1988;33:915–920 Lebovic DI, Mueller MD, Taylor RN: Immunobiology of endometriosis. Fertil Steril 2001;75:1–10 Bischoff FZ, Simpson JL: Heritability and molecular genetic studies of endometriosis. Hum Reprod Update 2000;6:37–44 Georgiou I, Syrrou M, Bouba I, Dalkalitsis N, Paschopoulos M, Navrozoglou I, Lolis D: Association of estrogen receptor gene polymorphisms with endometriosis. Fertil Steril 1999;72: 164–166 Kitawaki J, Obayashi H, Ishihara H, Koshiba H, Kusuki I, Kado N, Tsukamoto K, Hasegawa G, Nakamura N, Honjo H: Estrogen receptor-alpha gene polymorphism is associated with endometriosis, adenomyosis and leiomyomata. Hum Reprod 2001;16:51–55 Baranova H, Canis M, Ivaschenko T, Albuisson E, Bothorishvilli R, Baranov V, Malet P, Bruhat MA: Possible involvement of arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 genes in the development of endometriosis. Mol Hum Reprod 1999;5:636–641 Baranova H, Bothorishvilli R, Canis M, Albuisson E, Perriot S, Glowaczower E, Bruhat MA, Baranov V, Malet P: Glutathione S-transferase M1 gene polymorphism and susceptibility to endometriosis in a French population. Mol Hum Reprod 1997;3:775–780 Takayama K, Zeitoun K, Gunby RT, Sasano H, Carr BR, Bulun SE: Treatment of severe postmenopausal endometriosis with an aromatase inhibitor. Fertil Steril 1998;69:709–713 Dizerega GS, Barber DL, Hodgen GD: Endometriosis: Role of ovarian steroids in initiation, maintenance, and suppression. Fertil Steril 1980;33:649–653 Lessey BA, Metzger DA, Haney AF, McCarty KS, Jr: Immunohistochemical analysis of estrogen and progesterone receptors in endometriosis: Comparison with normal endometrium during the menstrual cycle and the effect of medical therapy. Fertil Steril 1989;51:409–415 Ball P, Knuppen R: Catecholestrogens (2-and 4-hydroxyestrogens): Chemistry, biogenesis, metabolism, occurrence and physiological significance. Acta Endocrinol 1980;232(Suppl): 1–127 Martucci CP, Fishman J: P450 enzymes of estrogen metabolism. J Pharmacol Ther 1993;57:237–257 Mannisto PT, Kaakkola S: Catechol-O-methyltransferase (COMT): Biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selectiveCOMTinhibitors. Pharmacol Rev 1999;51:593–628 Lavigne JA, Helzlsouer KJ, Huang HY, Strickland PT, Bell DA, Selmin O, Watson MA, Hoffman S, Comstock GW, Yager JD: An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer. Cancer Res 1997;57:5493–5497 Thompson PA, Shields PG, Freudenheim JL, Stone A, Vena JE, Marshall JR, Graham S, Laughlin R, Nemoto T, Kadlubar FF, Ambrosone CB: Genetic polymorphisms in catechol-Omethyltransferase, menopausal status, and breast cancer risk.Cancer Res 1998;58:2107–2110 Bulun SE, Zeitoun KM, Kilic G: Expression of dioxin-related transactivating factors and target genes in human eutopic endometrial and endometriotic tissues. Am J Obstet Gynecol 2000;182:767–775 Hoffman EC, Reyes H, Chu FF, Sander F, Conley LH, Brooks BA, Hankinson O: Cloning of a factor required for activity of the Ah (dioxin) receptor. Science 1991;252:954–958 Buttram VC, Jr: Evolution of the revised American Fertility Society classification of endometriosis. Fertil Steril 1985;43: 347–350 Tenhunen J, Salminen M, Lundstrom K, Kiviluoto T, Savolainen R, Ulmanen I: Genomic organization of the human catechol-O-methyltransferase gene and its expression from two distinct promoters. Eur J Biochem 1994;223:1049–1059 Bulun SE, Zeitoun KM, Takayama K, Sasano H: Estrogen biosynthesis in endometriosis: Molecular basis and clinical relevance. J Mol Endocrinol 2000;25:35–42 Yager JD, Liehr JG: Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol 1996;36: 203–232 Zeitoun K, Takayama K, Sasano H, Suzuki T, Moghrabi N, Andersson S, Johns A, Meng L, Putman M, Carr B, Bulun SE: Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: Failure to metabolize 17beta-estradiol. J Clin Endocrinol Metab 1998;83:4474–4480 De Leon FD, Vijayakumar R, Brown M, Rao CV, Yussman MA, Schultz G: Peritoneal fluid volume, estrogen, progesterone, prostaglandin, and epidermal growth factor concentrations in patients with and without endometriosis. Obstet Gynecol 1986;68:189–194 Chakraborty C, Huet-Hudson YM, Dey SK: Catecholestrogen synthesis and metabolism in the rabbit uterus during the periimplantation period. J Steroid Biochem 1990;35:39–46 Paria BC, Lim H, Wang XN, Liehr J, Das SK, Dey SK: Coordination of differential effects of primary estrogen and catecholestrogen on two distinct targets mediates embryo implantation in the mouse. Endocrinology 1998;139:5235–5246 Chakraborty C, Dey SK: Catecholestrogen formation in the mouse uterus and its role in implantation. Mol Cell Endocrinol 1990;69:25–32 Kelly RW, Abel MH: A comparison of the effects of 4-catechol estrogens and 2-pyrogallol estrogens on prostaglandin synthesis by the rat andhumanuterus. J Steroid Biochem 1981;14:787–791 Liehr JG, Ricci MJ, Jefcoate CR, Hannigan EV, Hokanson JA, Zhu BT: 4-Hydroxylation of estradiol by human uterine myometrium and myoma microsomes: Implications for the mechanism of uterine tumorigenesis. Proc Natl Acad Sci USA 1995;92:9220–9224 Hadfield RM, Manek S, Weeks DE, Mardon HJ, Barlow DH, Kennedy SH: OXEGENE Collaborative Group. Linkage and association studies of the relationship between endometriosis and genes encoding the detoxification enzymes GSTM1,GSTT1and CYP1A1. MolHumReprod 2001;7: 1073–1078 Author information Authors and Affiliations Corresponding author Rights and permissions About this article Cite this article Wieser, F., Wenzl, R., Tempfer, C. et al. Catechol-O-Methyltransferase Polymorphism and Endometriosis. J Assist Reprod Genet 19, 343–348 (2002). https://doi.org/10.1023/A:1016062726783 Issue date: DOI: https://doi.org/10.1023/A:1016062726783